Stay updated with breaking news from Technology Access Pool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UNAIDS welcomes the agreement between the Medicines Patent Pool (MPP) and the pharmaceutical company Merck Sharp & Dohme through which the intellectual property rights over an antiviral medicine to treat mild to moderate forms of COVID-19 in adult patients are shared with interested sub-licensees on a non-exclusive and transparent basis. The new medicine, molnupiravir, is
UNAIDS welcomes the agreement between the Medicines Patent Pool (MPP) and the pharmaceutical company Merck Sharp & Dohme through which the
NeelikaMalavige, a professor at Sri Lanka's Sri Jayewardenepura University has been appointed as a member of the World Health Organization's Technical Advisory Committee on Covid 19.
WHO and Unitaid welcome the signing of a voluntary licensing agreement by the Medicines Patent Pool (MPP) and MSD to facilitate affordable access to
Developing countries have been hit with an endless tide of inadequate gestures and broken promises from rich countries and pharmaceutical companies